Nektar Therapeutics
NKTR· Nasdaq
Released Aug 8, 2019, after the close
10-Q filed Aug 9, 2019, 40 days after period end · 0000906709-19-000006
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Revenue | $23.32M | $1.09B | $34.59M | $32.77M |
| Net Income | -$110.29M | $971.46M | -$59.87M | -$48.60M |
| EPS Diluted |
Nektar Therapeutics · CIK 906709 · Engraved from SEC EDGAR
| -$0.63 |
| $5.33 |
| -$0.39 |
| -$0.36 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.